跳至主要内容
临床试验/NCT04483882
NCT04483882已完成不适用

Utility and Efficacy of Tactile Labeling of Ophthalmic Drops for Identity and Frequency of Administration in Low Vision

The University of Texas Medical Branch, Galveston2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2020年7月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
2
主要终点
Correct Drug Identity by Color

研究概览

简要总结

The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch (UTMB) in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency with which they should be administered. The labeling strategy includes protrusions as frequency markers and shapes to differentiate between treatments of similar frequency prescription.

详细描述

The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch (UTMB) in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency with which they should be administered. The labeling strategy includes protrusions as frequency markers and shapes to differentiate between treatments of similar frequency prescription.

The first aim is to evaluate the patient capability to identify the number of protrusions and therefore the frequency of administration prescribed. This should be completed in a timeframe that is not frustrating or problematic to the patient in practice.

The second aim is to evaluate the patient ability to differentiate between drugs with similar frequencies based on a shape on the frequency protrusions in a tactile manner. This also should be completed in a timeframe that is not over burdensome or frustrating to the patient. The protocol is designed to evaluate this tactile labeling design in the population it is designed to support.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
Single (Participant)

盲法说明

Subjects will be blinded to product to be provided for visual and tactile definition of label product and type and frequency of prescription.

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Candidates will be healthy adults between 18 and 100 years of age
  • Candidates will complete the consent briefing and consent documents prior to participating in any study activities.
  • Phase II:Inclusion Criteria:
  • Candidates will be between 50 and 100 years of age.
  • Candidates will have a BCVA equal to or less than 20/70 or have central vision field less than 20 degrees.
  • Candidates will complete the consent briefing and consent documents prior to participating in any study activities.

排除标准

  • Candidates who do not complete the consent briefing and indicate consent through completion of consent documents with or without a witness (as indicated by their ability to read the documents for themselves out loud with whatever optical assistance necessary (large print, magnification, optical correction, etc.), prior to any study activity, will not be included in this study.
  • History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.
  • Candidates under 50 years or older than 100 years of age will be excluded.
  • Candidates with a BCVA better than 20/70 or have central vision field greater than 20 degrees, will be excluded.
  • Candidates with comorbidities that in the opinion of the investigator confound their ability to complete the assessments in this study (ie. Advanced neuropathy of the hands, dementia, or mental incapacity) will be excluded.
  • Candidates who do not complete the consent briefing and indicate consent through completion of consent documents with or without a witness (as indicated by their ability to read the documents for themselves out loud with whatever optical assistance necessary (large print, magnification, optical correction, etc.), prior to any study activity, will not be included in this study.
  • History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.

结局指标

主要结局

Correct Drug Identity by Color

时间窗: 2 minutes

Subject Assessment and Report of drug identity by color of tactile label

Correct Dose Frequency by Tactile Protrusions

时间窗: 2 minutes

Subject Assessment and Report of Drug Dosing frequency by number of protrusions of tactile label

Correct Drug Identity by Shape

时间窗: 2 minutes

Subjects Assessment and Report of drug identity by shape of label protrusions

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Tactile Low Vision Labeling of Ophthalmic Drops | 临床试验